Patients were considered to be on treatment for the period during which prescriptions were refilled before the estimated end date of the most recent prescription, including a 90-day grace period, i.e
Physician-led care: Detailed medical intake, frequent consults, and a clinician who specializes in obesity medicine
Why GLP-1 Medications Can Cause Nausea GLP-1 medications used for weight management can reduce appetite, increase fullness, and slow stomach emptying
For most patients, doctors consider several key factors when determining eligibility: Body mass index (BMI): Typically recommended for those with a BMI over 30, or over 27 if weight-related conditions such as diabetes, hypertension, or sleep apnea are present
Subcutaneous Injection (Recommended) Subcutaneous injection delivers MT-II directly into the fat layer beneath the skin, bypassing the digestive system entirely
doi: 10.1007/s11011-021-00673-z 61 KulasJAWeigelTKFerrisHA